Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects

被引：0
|
作者：
Beibei Liang
Jin Wang
Guanxuanzi Zhang
Rui Wang
Yun Cai
机构：
[1] PLA General Hospital,Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center of Chinese
来源：
Neurology and Therapy | 2023年 / 12卷
关键词：
Aldose reductase inhibitor; Diabetic peripheral neuropathy; Pharmacokinetics; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：947 / 959
页数：12
相关论文
共 50 条
  • [1] Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
    Liang, Beibei
    Wang, Jin
    Zhang, Guanxuanzi
    Wang, Rui
    Cai, Yun
    NEUROLOGY AND THERAPY, 2023, 12 (03) : 947 - 959
  • [2] Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects
    Chen, Xia
    Hu, Pei
    Vaccaro, Nicole
    Polidori, David
    Curtin, Christopher R.
    Stieltjes, Hans
    Sha, Sue
    Weiner, Sveta
    Devineni, Damayanthi
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1483 - 1492
  • [3] Single-dose and multiple-dose pharmacokinetics and safety of telbivudine after oral administration in healthy Chinese subjects
    Hu, Pei
    Jiang, Ji
    Wang, Hongyun
    Pietropaolo, Keith
    Chao, George C.
    Brown, Nathaniel A.
    Zhou, Xiao-Jian
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 999 - 1007
  • [4] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
    Yingxin Li
    Yang Li
    Li Li
    Wei Xue
    Kong Xin
    Titi Wang
    Aixin Shi
    Clinical Drug Investigation, 2023, 43 (6) : 413 - 420
  • [5] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
    Li, Yingxin
    Li, Yang
    Li, Li
    Xue, Wei
    Xin, Kong
    Wang, Titi
    Shi, Aixin
    CLINICAL DRUG INVESTIGATION, 2023, 43 (06) : 413 - 420
  • [6] Pharmacokinetics, Safety and Tolerability of Sacubitril/Valsartan (LCZ696) After Single-Dose Administration in Healthy Chinese Subjects
    Yi Han
    Surya Ayalasomayajula
    Wei Pan
    Fan Yang
    Yaozong Yuan
    Thomas Langenickel
    Markus Hinder
    Sampath Kalluri
    Parasar Pal
    Gangadhar Sunkara
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 109 - 116
  • [7] Pharmacokinetics, Safety and Tolerability of Sacubitril/Valsartan (LCZ696) After Single-Dose Administration in Healthy Chinese Subjects
    Han, Yi
    Ayalasomayajula, Surya
    Pan, Wei
    Yang, Fan
    Yuan, Yaozong
    Langenickel, Thomas
    Hinder, Markus
    Kalluri, Sampath
    Pal, Parasar
    Sunkara, Gangadhar
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (01) : 109 - 116
  • [8] Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open-label, single-dose, randomized study in healthy Chinese subjects
    Chen, Qian
    Qian, Hong-jie
    Wang, Wei
    Zhang, Meng-qi
    Lu, Dong-ying
    Lu, Chuan
    Jin, Jie-mei
    Hu, Chao-ying
    Liu, Gang-yi
    Jia, Jing-ying
    Zheng, Hong-chao
    Li, Xue-ning
    Yu, Chen
    Wang, Yi-ping
    Liu, Yun
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (01) : 120 - 125
  • [9] Single-Dose Pharmacokinetics, Safety, and Tolerability of Modified-Release Formulations of Lersivirine in Healthy Subjects
    Vourvahis, Manoli
    Wang, Ronnie
    da Costa, Laure Mendes
    Wang, Cunshan
    Weatherley, Barry
    Mukwaya, Geoffrey
    Tawadrous, Margaret
    Heera, Jayvant
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 472 - 476
  • [10] Single-dose and steady-state pharmacokinetics and safety of telbivudine following oral administration in healthy Chinese subjects
    Hu, P.
    Jiang, J.
    Wang, H.
    Pietropaolo, K.
    Chao, G.
    Brown, N.
    Zhou, X.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A129 - A129
12345